CDK4/6 Inhibitor Resistant Breast Cancer Models

Leverage our extensive panel of CDK4/6 inhibitor resistant breast cancer models, including: 

  • In vitro induced Palbociclib resistant MCF-7 cell line
  • In vivo induced Palbociclib resistant MCF-7 model
  • In vivo induced Abemaciclib resistant MCF-7 model
  • In vivo induced Ribociclib resistant MCF-7 model

View additional drug-resistant models in our platform


WuXi AppTec CDK4_6 inhibitor resistant models-Newsletter

Download

← Return to Resources

Related Content

High-throughput FAMA Assay to Measure Humoral Immunity against Varicella-Zoster Virus

Varicella-zoster virus (VZV) is a highly contagious alpha-herpesvirus that infects more than 90% of people worldwide. The primary infection with...

VIEW RESOURCE

An Effective System for Senescence Modulating Drug Development

Cellular senescence plays a crucial role in aging and age-related diseases, making its study essential for the development of new...

VIEW RESOURCE
← View all Cell-based Assays Resources
× peptide, amino acid

Contact An Expert Today!

Contact Us